USPTO patent commissioner Focarino to retire in July

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

USPTO patent commissioner Focarino to retire in July

peggy-focarino-150.jpg

Peggy Focarino has announced she will retire as patent commissioner at the USPTO on July 3

peggy-focarino-150.jpg

Focarino took over as patent commissioner in January 2012, replacing Robert Stoll. She previously was deputy patent commissioner.

Focarino began her career at the USPTO in 1977 as a patent examiner. She was promoted to the senior executive service in 1997.

“Peggy has been an inspiration to so many individuals who have aspired to further American innovation through public service,” said Michelle Lee, director of the USPTO. “Since 1977, when she began her career as a patent examiner, she has proven to be a role model of professionalism and dedication. Her tenure as Commissioner for Patents occurred at a historic moment in the patent system’s 225-year history, during the enactment of the transformative America Invents Act. I am grateful for the opportunity to have worked with her over the last several years, and congratulate her on an extremely successful career.”





more from across site and SHARED ros bottom lb

More from across our site

Richard de Bodo, who had a lengthy career at international firms, shares how he will address client needs and praises the unique offerings of smaller firms
An Australian top court decision clarifying honest concurrent use and wins by publishers against AI platforms were also among the top talking points
AIPPI has pulled the plug on its planned 2027 World Congress, and INTA has delayed hosting a meeting there, but the concerns won’t abate
Despite being outspent by a wealthy opponent, a trial attorney at King & Spalding says ‘relentless pursuit of the truth’ helped his team secure a $420m damages award for mobile gaming client
190 drugs face loss of exclusivity between 2026 and 2030, with the list including Bristol Myers Squibb’s blood-thinning drug Eliquis and immunotherapy medication Opdivo
Nokia, represented by a team from Bird & Bird, adjudged to have made fair offer to Asus and Acer in UK SEP dispute
Azhar Sadique and Kane Ridley, who founded the London office in 2023, are now both working in legal tech and AI-related roles, while another UK-based lawyer has also left
Partner Pierre Pérot rejoins the firm he left in 2022 alongside another returning lawyer, associate Camille Abba
Vaping dispute, in which Stobbs and Brandsmiths are the representatives, tested how the UK's Human Rights Act can apply to injunctions restraining unjustified threats
An AI platform being sold for £40m, and lateral hires involving law firms Womble Bond Dickinson and Cadwell Thomas were among the top talking points
Gift this article